- Roche KRAS drug succeeds in head-to-head lung cancer study<figure><div><img src="https://imgproxy.divecdn.com/Sx5xDgNmDFUjqj0qcGVTS7IkwSLxPHMSmgzypS8Uexg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xOTM3MjY1MDU5XzEua…BioPharma Dive · 24d ago↗ source
- STAT+: Roche drug sets new standard for KRAS-driven lung cancerBiotech's bull market, Vertex's gene therapy expansion, and more news from The ReadoutSTAT · 24d ago↗ source
- STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and moreU.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug EnbrelSTAT · 24d ago↗ source